Early-life EBV infection protects against persistent IgE sensitization

Area of Science:

• Immunology
• Allergy Research
• Pediatric Infectious Diseases

Background:

• Epstein-Barr virus (EBV) infection's role in allergic disorders is debated, with infection timing potentially explaining conflicting findings.
• Understanding EBV's influence on allergy development is crucial for public health.

Purpose of the Study:

• To investigate if the timing of primary Epstein-Barr virus (EBV) infection in childhood impacts the risk of developing immunoglobulin E (IgE) sensitization.
• To clarify the relationship between early-life EBV exposure and allergic sensitization.

Main Methods:

• Prospective cohort study of 219 Swedish infants followed to age 5.
• Clinical examinations, skin prick testing, specific IgE analysis, and EBV serostatus determination were performed.
• Statistical analysis of EBV serostatus and IgE sensitization at ages 2 and 5.

Main Results:

• Infants infected with EBV before age 2 had a significantly lower risk of persistent IgE sensitization by age 5 (aOR 0.34).
• EBV infection after age 2 was strongly associated with late-onset IgE sensitization (aOR 4.64).
• Persistently sensitized children exhibited higher specific IgE levels compared to those with late-onset sensitization.

Conclusions:

• Early-life microbial exposures, including EBV, may protect against IgE sensitization.
• The early postnatal period is critical for EBV's potential role in establishing an allergo-protective immune profile.
• Findings support the hygiene hypothesis and the importance of early environmental interactions for immune development.